Lausanne, Switzerland – July 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Héritas SA, an Argentinian precision-medicine company. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Héritas’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.
Fabian Fay, co-founder of Héritas, said: ‘This new partnership will help us to deliver high-quality, state-of-the-art clinical-certified bioinformatics services bundled to our high-quality production of genetic data for our products FOCUS® and CLEAR® to ensure that customers receive best-quality, clinically-certified actionable information for their patients, but also to directly support clinicians and clinical labs who want to analyze their own genetic raw data.”
Andreas Massouras, CEO and Founder of Saphetor SA, commented: ‘We are excited to count Héritas among our regional distributors for our bioinformatics tools, and we are prepared to work closely with their team to provide their clients with an integrated solution for diagnostics purposes.’
About Héritas SAHéritas SA is a precision medicine data-driven company from Argentina that delivers high-quality clinical genetic testing with the highest level of confidence, security and state-of-the-art technology, fundamentally aimed to transform health-care in every patient. Héritas delivers products and services in a wide range of genetic testing such as FOCUS® (clinical exome), CLEAR® (hereditary cancer), CHROMO® (CGH Array for pediatric hereditary conditions), VISION® (non-invasive prenatal testing), ONCOSENS® (tumour genomic profiling in plasma) and MICROXPLORA® (gut microbiome testing for human diseases). Héritas produces high-quality certified genetic data in its own production platform using Illumina systems and delivers high-quality analyses through its own data science platform and medical genetics platform.
About Saphetor SA
Saphetor SA, is a Swiss precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge. Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. VarSome.com search engine and professional community is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than 30 genetic and genomic data resources. VarSome Pro and VarSome Clinical are professional editions of VarSome with powerful functionality and further sophisticated data-mining and analysis tools. While VarSome Pro serves researchers, VarSome Clinical is a clinically-accredited platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels, which help clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions.